[Revealed] Trump and Elon's Shocking New Plan for America

Three patents could help President Trump and Elon Musk completely revolutionize a $23 Trillion market. This revolution is about so much more than just self-driving cars. Instead, what Elon's pivoting Tesla towards... Is a market that's 1,000X BIGGER. But a project THIS big can't stay under the radar for long...

Eventful Monday For AstraZeneca - What's Going On?

Vandana Singh
March 17, 2025

On Monday, AstraZeneca Plc (NASDAQ:AZN) released high-level results from the CALYPSO Phase 3 trial designed to evaluate the efficacy and safety of eneboparatide in adults with chronic hypoparathyroidism.

The study showed that eneboparatide (AZP-3601), an investigational parathyroid hormone (PTH) receptor 1 agonist, met its primary endpoint with statistical significance at 24 weeks in adults with chronic hypoparathyroidism (HypoPT) compared to placebo.

The primary endpoint is a composite of normalization of albumin-adjusted serum calcium levels and independence from active vitamin D and oral calcium therapy.

Also Read: AstraZeneca’s Imfinzi-Based Regimen Shows Improved Event-Free Survival In Early-Stage Gastric Cancer Patients

HypoPT is a rare endocrine disease caused by a deficiency of PTH and is characterized by impaired regulation of calcium and phosphate levels in the blood. Eneboparatide was well tolerated.

After the 24-week randomized treatment period, all patients receive eneboparatide in the ongoing long-term extension until 52 weeks. Full efficacy and safety data will be analyzed at 52 weeks.

Concurrently, AstraZeneca and Alteogen entered into an exclusive license agreement for ALT-B4, a hyaluronidase utilizing Hybrozyme platform technology.

Under the terms of the agreement, AstraZeneca will acquire worldwide rights to use ALT-B4 to develop and commercialize subcutaneous formulations of several oncology assets.

Alteogen will be responsible for the clinical and commercial supply of ALT-B4 to AstraZeneca.

AstraZeneca will pay Alteogen an upfront payment and additional payments upon achieving specific development, regulatory, and sales-related milestones. Additionally, Alteogen will receive royalties on the sales of the commercialized products.

On Monday, the European Union approved AstraZeneca’s Imfinzi (durvalumab) as monotherapy for adults with limited-stage small cell lung cancer whose disease has not progressed following platinum-based chemoradiation therapy.

The approval is based on results from the ADRIATIC Phase 3 trial.

The trial showed that Imfinzi reduced the risk of death by 27% compared to placebo.

The estimated median overall survival was 55.9 months for Imfinzi versus 33.4 months for placebo. An estimated 57% of patients treated with Imfinzi were alive at three years compared to 48% for placebo.

Imfinzi also reduced the risk of disease progression or death by 24% versus placebo.

The median progression-free survival (PFS) was 16.6 months for Imfinzi versus 9.2 months for placebo. An estimated 46% of patients treated with Imfinzi had not experienced disease progression at two years compared to 34% for placebo.

Earlier on Monday, AstraZeneca agreed to acquire cell therapy focused-EsoBiotec SA for up to $1 billion.

Price Action: At the last check on Monday, AZN stock was down 1.04% to $76.78 during the premarket session.

Read Next:

  • Hain Celestial Valuation Is Low Versus Historical Levels, But Analyst Remains Neutral – Here’s Why

Image by Robert Way via Shutterstock

Continue Reading...

Popular

Nvidia CEO Jensen Huang discusses AI's future at GTC 2025

Nvidia founder Jensen Huang kicked off the company's artificial intelligence developer conference on Tuesday by telling a crowd of thousands that AI is going through “an inflection point.”

Canadian man sentenced to 25 years for shootings that damaged pipeline and power station in Dakotas

BISMARCK, N.D. (AP) — A Canadian man has been sentenced to 25 years in federal prison for shootings at an oil pipeline in South Dakota and an electrical substation in North Dakota that caused $1.7 million in damages after a judge found that his crimes met the definition of terrorism.

DOGE's Next Target Set To Hand 401K Savers A Windfall? - Ad

Musk's Department of Government Efficiency has already uncovered $55B in waste--and Trump's backing his plan to return $2T in savings to taxpayers. But why wait? Unlock a legal Trump IRS loophole to protect & grow your wealth NOW!

China learned from Trump's first trade war and changed its tactics when tariffs came again

WASHINGTON (AP) — The leaders of both Canada and Mexico got on the phone with President Donald Trump this past week to on their countries, but China’s president appears unlikely to make a similar call soon.

NBA Legend Shaq's Walmart Shopping Spree Ends In Credit Card Decline - Here's How Much He Tried To Spend

Basketball superstar Shaquille O'Neal's impact goes beyond basketball, with his larger-than-life personality and smart investments. Yet, one of his most unforgettable moments happened at Walmart.

Are you owed an extra $2,105 a month in extra cash? - Ad

A little-known "loophole" has allowed a handful of regular Americans to legally collect over $109,200,000 in bonus cash. And today's your chance to join them. It doesn't matter how old you are or even how much money you make. And my research shows there's no way you can be denied from taking part in this opportunity.

Warren Buffett Rakes In $607 Million While Elon Musk, Jeff Bezos, And Other Top Moneybags Bleed $67 Billion In A Day Amid Market Wipeout

The world's top tech billionaires saw their fortunes plummet on Monday as markets tumbled, with the Magnificent Seven tech giants shedding approximately $780 billion in market capitalization during a single trading session.

Meet the federal worker who went rogue: I hope that it lights a fire under people

NEW YORK (AP) — To billionaire Elon Musk and his cost-cutting team at the Department of Government Efficiency, Karen Ortiz may just be one of many faceless bureaucrats. But to some of her colleagues, she is giving a voice to those who feel they can't speak out.

Steve Bannon Accidentally Revealed 'Secret' Trump Plan? - Ad

With one executive order, Trump could dismantle the rigged financial system--and return America to the gold standard. He's been stockpiling gold since 1974... should you? Discover the "Trump Loophole" to move funds from your IRA & 401(k) into gold--tax free!

Trump-Announced Strategic Bitcoin Reserve To Allow Buying Additional BTC? Peter Schiff Doesn't Think So But Here's What The Order Says

President Donald Trump's executive order establishing a Strategic Bitcoin (CRYPTO: BTC) Reserve did not have the expected bullish impact on Thursday, as the leading cryptocurrency dropped on the announcement.

Explainer: What's a recession and why is rising anxiety about it roiling markets?

WASHINGTON (AP) — Stock markets , consumers and businesses have started to , and economists are marking down their estimates for growth this year, with some even seeing rising odds of a recession.

13-Second Trump Video Could Trigger AI Shock - Ad

Louis Navellier, the legendary investor who picked Nvidia before shares exploded as high as 3,423%... Just released a video with this 13-second Trump clip about the current AI boom. Please, do NOT buy any AI stock before watching that clip. What President Trump said in that clip could have implications for this AI boom.

Alibaba Unveils New AI Chip To Power China's Open-Source Tech Push, Challenge US Chip Giants

Alibaba's new processor, XuanTie C930, boosts China's semiconductor industry by promoting open-source chips & AI acceleration, amid US sanctions.

Greenland in facts and figures

NUUK, Greenland (AP) — is having a moment in the spotlight as U.S. President Donald Trump maneuvers to gain control of the mineral-rich Arctic country. Here are some facts and figures about it:

Stocks to Crash on March 16, 2026? Here's Compelling Reason Why - Ad

Perhaps no one on or off Wall Street has been more accurate calling the bull and bear turns of the past 7 years. From the bear markets of 2018 and 2022... to the roaring bull runs of 2021, 2023, and 2024. And now, Marc Chaikin is predicting the next crash will start March 14, 2026. If you have money in the markets, Chaikin's thesis is a must-see.

CompoSecure Beats EBITDA Estimates But Analyst Cuts Price Forecast Amid Resolute Spin-Off And Growth Outlook

Analyst maintains Buy rating & lowers price target for CompoSecure Inc after Q4 revenue & EBITDA miss, but gains comfort with Resolute spin & Arculus profitability.

Japan's Seven & i sells retail business to Bain Capital for $5.4 billion, plans IPO

Japan’s Seven & i, the parent company of the Japanese 7-Eleven convenience store chain, said Thursday it is selling its supermarket store assets to Bain Capital for about $5.4 billion.

The $240M AI Disruptor - Ad

This Nasdaq-listed company is redefining AI in the $124 billion smart glass market. From cockpit shading systems to energy-efficient building glass, their technology powers global leaders like Boeing, Mercedes-Benz, and National Geographic. Their projected $240M revenue from aerospace positions them as an AI-driven market disruptor you can't ignore.

Warren Buffett on Debt and Donald Trump's Money Moves: Trump 'Never Went Right'

In a piece of advice that continues to hold relevance, investor Warren Buffett once warned students about the perils of excessive borrowing, citing Donald Trump as a case in point.

Canada Claps Back At 'Unjustified' Trump Tariffs On Dairy, Lumber

Canada's Trade Minister Mary Ng called the potential dairy tariffs "completely unjustified" and emphasized efforts to remove existing tariffs.

Elon's Biggest Secret Could Save Your Retirement - Ad

From a near-fatal car crash to surviving deadly malaria, Musk's fearless drive built Tesla, SpaceX, and Starlink. Now, he's warning America--and smart investors are listening. Discover the Trump IRS Loophole to protect your IRA & 401(k).

Bristol Myers Acquired MyoKardia Drops Fulcrum Agreement, Ending Cardiomyopathy Research Deal

MyoKardia, a Bristol Myers unit, is terminating its agreement with Fulcrum Therapeutics, ending a cardiomyopathy research deal set to expire in June 2025.

Tesla Out, Ford In: City Of Baltimore Goes 'In A Different Direction' Reversing EV Deal From 2024

Tesla is losing an EV city fleet deal in Baltimore to Ford. A look at what happened and how politics may have factored into the decision.

Millionaire Trader: "My No. 1 Stock of the Decade" (Revealed Free) - Ad

The stock revealed right here just may be millionaire trader Jeff Clark's favorite stock ever. Because this one stock alone has been responsible for some of the biggest gains he's ever handed my readers... 195% in under a month... 85% in 14 days... 176% in 5 weeks... 120% in under 3 months... 55% in two days... 138% in 8 days... And even 222% in 8 days.

Panama president calls Trump's talk of 'reclaiming' the Panama Canal a lie

PANAMA CITY (AP) — Panama President José Raúl Mulino on Wednesday accused U.S. President Donald Trump of lying when he said in his address to Congress that his administration was “reclaiming” the Panama Canal.

CDC Considers New Autism Study As Vaccine Safety Debate Persists

The CDC is planning a large study on potential vaccinAutism's links, despite extensive research dismissing any connection.

Globetrotting CFA Discovers Top Four Gold Miners With 100X Upside Potential - Ad

Most CFAs sit at a desk... But one unusual CFA went all-in on gold investing 20 years ago... and accidentally positioned himself as the expert's expert for the current bull market. Garrett Goggin's research has led him to the the Top Four miners sitting on potential upside of 100X or more for the current gold mania. He's been offered as much as $100k by Hedge Funds.

Mineralys Therapeutics Unveils Positive Data From Two Trials For Hypertension Drug Candidate

Mineralys Therapeutics' lorundrostat met key Phase 3 and Phase 2 trial endpoints for hypertension, showing significant blood pressure reductions and a strong safety profile.

Greece says ambitious Mediterranean power cable project is on track despite setbacks

ATHENS, Greece (AP) — The future of an ambitious electricity cable linking the power grids of , and Israel by the end of the decade is on track despite a series of setbacks, Greece’s Foreign Minister Giorgos Gerapetritis said Thursday.

Gold's About to Go Parabolic? (Trump's First Term Sent It Soaring) - Ad

During President Trump's first term, tariffs & rate cuts sent gold soaring 57%. Now, Trump is using the same playbook. Are you expecting different results? Hint: Gold is now surging, and experts predict gold could hit $4,000... even $10,000! Move funds from your IRA & 401(k) into gold--TAX & PENALTY-FREE--while you still can!

AOC Claps Back At Mike Johnson As Senate Moves Closer To Government Shutdown: 'If You Need Democrats, Then You Need To Negotiate'

Alexandria Ocasio-Cortez pushed back on Speaker Mike Johnson's blame for a possible shutdown, reminding him that Republicans control the government and must negotiate if they lack the votes.

Warren Buffett Is The 'GOAT,' Says Lawrence McDonald As Bill Ackman Predicts A Stronger Berkshire After The Oracle Of Omaha Eventually Steps Down

Lawrence McDonald, founder of Bear Traps Report, called Warren Buffett the "GOAT" of asset management on Sunday while noting the legendary investor put "very little capital to work" during the 2020 COVID market drawdown compared to 2022's market stress.

Bill Gates' Next Big AI Bet: Stargate Could Be a Game-Changer - Ad

Jeff Brown, the tech expert who predicted Bitcoin, Nvidia, and Tesla, reveals Bill Gates' new AI project, Stargate. Could this be the next big AI breakthrough?

Japan's economy grew at a 2.2% annual rate in Oct-Dec, as consumers held back on spending

TOKYO (AP) — Japan’s has cut its estimate for its economic growth in the last quarter of the year to a 2.2% annual pace from 2.8% as consumer spending hit demand.

How to roll over an old 401(k)

Old are a little like the old clothes in the back of your closet. You know you should do something about them, but there they sit, mostly out of sight and mind.

Trump's Tariff Move Has Created a Massive Opportunity for 401(K)S - Ad

As President Trump slaps China with new tariffs, the Fed is boxed in--and gold is skyrocketing just like it did during Trump's first term. JPMorgan just grabbed $4 Billion in gold bars... should you? Discover a "Tariff Assistance Loophole" to move funds from your IRA & 401(k) into gold--tax-free!

A staff office for the US nuclear waste repository will no longer face DOGE cuts

ALBUQUERQUE, N.M. (AP) — Federal officials have backtracked on plans to cancel a lease for office space in New Mexico where dozens of U.S. Department of Energy employees who oversee the nation’s only underground nuclear waste repository are based.

Trump vs Musk? Federal Workers Unconvinced He'll Take Action: 'If They Don't Cut, Elon will, Comments Show Who's Really In Charge'

President Donald Trump has reportedly limited the authority of his billionaire advisor, Elon Musk, to dismiss federal employees. This development has stirred skepticism among the workforce and political circles.

AI + Smart Glass = A Nasdaq Sleeper - Ad

This recent Nasdaq IPO is quietly making waves, thanks to its 95% market share in a $240M aerospace niche. With patented technology that integrates AI into smart glass, this company is poised for massive growth as the market races toward $124 billion by 2029.

Albania shuts down TikTok for a year amid concerns over violence among children

TIRANA, Albania (AP) — The Albanian Cabinet decided on Thursday to shut down for 12 months, blaming the popular video-sharing platform for inciting violence and bullying, especially among children.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright finstrategist.com
Privacy Policy | Terms of Service